Targeted Therapies: Lung Cancer
Lung Cancer (January 2015)
Volume: 3
Issue: 1
Lung Cancer (May 2014)
Volume: 2
Issue: 1
Lung Cancer (Sept 2014)
Volume: 2
Issue: 2
Lung Cancer (May 2012)
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Subcutaneous Amivantamab for EGFR-Mutated NSCLC Indications
2
Enfortumab Vedotin Plus Pembrolizumab Improves Survival in MIBC
3
FDA Grants Regular Approval to Rucaparib for BRCA-Mutated mCRPC
4
Long-Term ECHO Data Support Concurrent Acalabrutinib/BR in MCL
5